BRIEF-EMA Starts Safety Review Of Janus Kinase Inhibitors For Inflammatory Disorders

Reuters | Updated: 11-02-2022 17:20 IST | Created: 11-02-2022 17:11 IST

BRIEF-EMA Starts Safety Review Of Janus Kinase Inhibitors For Inflammatory Disorders — Representative Image

EMA:

* EMA: EMA STARTS SAFETY REVIEW OF JANUS KINASE INHIBITORS FOR INFLAMMATORY DISORDERS: 11/02/2022 Source text for Eikon:

TRENDING

1

Italy to extend fuel excise duty cut expiring this week, minister says

Italy to extend fuel excise duty cut expiring this week, minister says

Global

2

UPDATE 1-European shares gain as Trump's Iran comments cheer markets

UPDATE 1-European shares gain as Trump's Iran comments cheer markets

Global

3

Italy to extend fuel excise duty expiring this week, minister says

Italy to extend fuel excise duty expiring this week, minister says

Global

4

FACTBOX-What's at stake in Armenia's June election?

FACTBOX-What's at stake in Armenia's June election?

Global

OPINION / BLOG / INTERVIEW

Faster hiring, deeper doubts: Probing the risks of AI recruitment

Generative AI creates transparency crisis in research

Digital inequality now goes beyond internet access as AI reshapes social exclusion

Building energy codes could help Global South cities cut emissions and climate risk

DevShots

Latest News

Connect us on

Facebook Twitter LinkedIn Quora Youtube

Google News RSS

Give Feedback

Name

Email

Message

Web Analytics Made Easy - Statcounter